BBI Life Sciences Corporation announced unaudited consolidated earnings results for the six months ended June 30, 2018. For the period, the company reported revenue of RMB 268,450,000 against RMB 220,216,000 a year ago. Operating profit was RMB 42,857,000 against RMB 33,133,000 a year ago. Profit before income tax was RMB 43,024,000 against RMB 33,285,000 a year ago. Total profit attributable to equity holders of the company was RMB 37,735,000 or RMB 0.069 per basic and diluted share against RMB 29,828,000 or RMB 0.055 per basic and diluted share a year ago. Net cash used in operating activities was RMB 114,000 against RMB 18,764,000 a year ago. Purchase of property, plant and equipment was RMB 47,552,000 against RMB 76,355,000 a year ago. Purchase of intangible assets was RMB 6,000 against RMB 199,000 a year ago.